These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 13925219

  • 1. [Treatment of the hydrosaline retention in hepatic cirrhosis with spironolactone].
    VELASCO M, GAZMURI R, KATZ R.
    Rev Med Chil; 1961 Oct; 89():846-51. PubMed ID: 13925219
    [No Abstract] [Full Text] [Related]

  • 2. [Spirolactones in the treatment of ascitogenic hepatic cirrhosis. Clinical and biological effects].
    BONINI A.
    Minerva Med; 1962 Jun 23; 53():1990-4. PubMed ID: 13871015
    [No Abstract] [Full Text] [Related]

  • 3. [Comments on the use of spirolactones in the treatment of ascitic cirrhosis (5 cases)].
    GRILLIAT JP, MARCHAL C, ANTOINE, SAPELIER P, KIFFER B.
    Rev Med Nancy; 1961 Jun 23; 86():801-20. PubMed ID: 13901929
    [No Abstract] [Full Text] [Related]

  • 4. Spironolactone (Aldactone) therapy for ascites due to cirrhosis of the liver.
    LOCKWOOD CH.
    Can Med Assoc J; 1961 Sep 09; 85(11):631-7. PubMed ID: 13763007
    [No Abstract] [Full Text] [Related]

  • 5. [Aldostegone-antagonistic steroids as diuretics. Spironolactone in the treatment of hepatic and cardiac edemas].
    LEPPLA W, TIEFENSEE H.
    Dtsch Med Wochenschr; 1961 Dec 08; 86():2395-402. PubMed ID: 14464199
    [No Abstract] [Full Text] [Related]

  • 6. [Trials of treatment of cirrhotic ascites with a spirolactone. Apropos of 7 cases].
    LEVRAT M, BRETTE R, FRANCOIS B, TISSOT A, MESTRALLET G.
    Lyon Med; 1961 May 14; 93():1115-23. PubMed ID: 13761576
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of the ascites and edema of cirrhotics by spironolactone].
    MINICONI P, BOURREILLE J, SUDUCA P, CARAYON P, LAVOCAT G, ISSAD H.
    Alger Medicale; 1962 Jan 14; 66():1-98. PubMed ID: 14474319
    [No Abstract] [Full Text] [Related]

  • 9. CIRRHOSIS--FLUID RETENTION AND ASCITES.
    VOLWILER W.
    Mod Treat; 1964 Mar 14; 1():451-61. PubMed ID: 14159599
    [No Abstract] [Full Text] [Related]

  • 10. [ON THE DIURETIC EFFECT OF THE ADRENOSTATIC DRUG METHOPYRAPONE].
    HIERHOLZER K.
    Dtsch Med Wochenschr; 1964 Jun 05; 89():1124-7. PubMed ID: 14152369
    [No Abstract] [Full Text] [Related]

  • 11. [Action of a spirolactone in an edematous syndrome of cirrhotic origin].
    HERBEUVAL R, CUNY G, DUHEILLE J, GUERCI O, PETITIER H.
    Rev Med Nancy; 1961 Jun 05; 86():778-84. PubMed ID: 13906642
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Diuretic effect of spironolactone (Sc-9420) in patients with cirrhosis of the liver with ascites].
    RIVERA A, SEPULVEDA B, LANDA L, CHAGOYA L.
    Rev Med Chil; 1961 Oct 05; 89():843-6. PubMed ID: 14038707
    [No Abstract] [Full Text] [Related]

  • 14. [ALDOSTERONE ANTAGONISTS IN THE TREATMENT OF CIRRHOTIC ASCITIS].
    GARCIA-RAMOSARRIAGA J.
    Acta Med Tenerife; 1963 Oct 05; 20():101-4. PubMed ID: 14093724
    [No Abstract] [Full Text] [Related]

  • 15. The use of a steroidal spirolactone in the treatment of ascites in hepatic cirrhosis.
    KERR DN, READ AE, HASLAM RM, SHERLOCK S.
    Lancet; 1958 Nov 22; 2(7056):1084-7. PubMed ID: 13599489
    [No Abstract] [Full Text] [Related]

  • 16. [WATER RETENTION IN CIRRHOTICS. PHYSIOPATHOLOGICAL DATA AND THERAPEUTIC RESULTS].
    CONTE M, FOUET P, JACOBS C.
    Bull Mem Soc Med Hop Paris; 1963 Nov 29; 114():1307-12. PubMed ID: 14098214
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [LIMITS OF TREATMENT OF CIRRHOSIS WITH DIURETICS (SALDIURETICS AND ALDOSTERONE ANTAGONISTS)].
    ALBEAUX-FERNET M, ROMANI JD.
    Bull Mem Soc Med Hop Paris; 1963 Nov 29; 114():1277-84. PubMed ID: 14098211
    [No Abstract] [Full Text] [Related]

  • 19. Medical management of ascites in cirrhosis of the liver. II. Aldosterone antagonists.
    RIVERA A, VELASCO F, SUAREZ MA, DIES F.
    Clin Pharmacol Ther; 1963 Nov 29; 4():154-61. PubMed ID: 13974133
    [No Abstract] [Full Text] [Related]

  • 20. [Transitory hyperazotemia during spirolactone treatment in a patient of cirrhosis].
    JUSTIN-BESANCON L, LAROCHE C, NENNA A, ETIENNE JP, LEBORGNE P.
    Bull Mem Soc Med Hop Paris; 1963 Nov 29; 76():1225-9. PubMed ID: 13791129
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.